Pharmaceuticals
Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market
The Turkish investigation was opened against Teva International, its subsidiary Teva Europe, and its subsidiary in Turkey to determine whether the law was violated.
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
Europe, Israel, and the medical record of a nation - opinion
How Evogene is changing the future for the pharma and agriculture markets
Novo Nordisk advances amycretin to late-stage trial after positive diabetes weight-loss results
Novo Nordisk’s experimental drug amycretin shows strong results in its mid-stage trial, helping type 2 diabetes patients lose up to 14.5% of their body weight.
Teva seeks startups to help solve global pharmaceutical challenges
Called Teva Rise, it aims to accelerate innovations such as AI, digital health, smart manufacturing and biotech
Trump warns pharmaceutical tariffs could reach 200%, gives 'a year to get their act together'
US President Donald Trump plans to implement a 200% tariff rate on pharmaceuticals, while he also announced tariffs on semiconductors and copper.
Israel’s healthcare workforce lags behind OECD averages despite growth in doctors and nurses
Despite an increase in medical professionals, Israel’s healthcare workforce remains below the OECD average, highlighting ongoing challenges.
Teva share price struggles to recover following $6 billion market loss
The financial results were actually positive, at the higher end of analysts' forecasts, but profit guidance for 2025 disappointed the market.
Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough
The Inside Israeli Innovation Podcast: Season 2, Episode 43.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
Israeli mapping company ImmunAI partners with AstraZeneca
The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant AstraZeneca for the advanced optimization of clinical trials.
Immunai, AstraZeneca collaborate to optimize cancer clinical trials
Under the terms of the agreement, AstraZeneca will leverage Immunai’s platform and machine learning capabilities to inform certain oncology clinical trials.
Kahun’s pharma-focused AI agent: Bridging medical knowledge and patient care
Kahun’s new AI Agent is revolutionizing healthcare by providing real-time, patient-specific medical insights, helping doctors stay updated on pharmaceutical developments while improving patient care.
